Respiratory Syncytial Virus (RSV) Vaccine Effectiveness Against RSV-associated Hospitalisations and Emergency Department Encounters among Adults Aged 60 Years and Older in the USA, October, 2023, to March, 2024: a Test-Negative Design Analysis Amanda B. Payne , Janet A. Watts , Patrick K. Mitchell , Kristin Dascomb , Stephanie A. Irving , Nicola P. Klein , Shaun J. Grannis , Toan C. Ong , Sarah W. Ball , Malini B. Desilva , Karthik Natarajan , Tamara Sheffield , Daniel Bride , Julie Arndorfer , Allison L. Naleway , Padma Koppolu , Bruce Fireman , Ousseny Zerbo , Julius Timbol , Kristin Goddard , Brian E. Dixon , William F. Fadel , Colin Rogerson , Katie S. Allen , Suchitra Rao , David Mayer , Michelle Barron , Sarah E. Reese , Elizabeth A. K. Rowley , Morgan Najdowski , Allison Avrich Ciesla , Josephine Mak , Emily L. Reeves , Omobosola Akinsete , Charlene E. Mcevoy , Inih J. Essien , Mark W. Tenforde , Katherine E. Fleming-Dutra , Ruth Link-Gelles LANCET(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper